Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema

被引:0
|
作者
Hooshang Faghihi
Bahman Inanloo
Arash Mirzaee
Kaveh Fadakar
Ahmad Mirshahi
Nazanin Ebrahimiadib
Fariba Ghassemi
Fatemeh Bazvand
Abdulrahman Amini
Masoud Mirghorbani
Shahin Faghihi
Elias Khalili Pour
Hamid Riazi-Esfahani
机构
[1] Tehran University Of Medical Sciences,Retina Service, Farabi Eye Hospital
来源
International Journal of Retina and Vitreous | / 8卷
关键词
Diabetic retinopathy; Refractory diabetic macular edema; Interferon-alpha; Anti-vascular endothelial growth factor (Anti-VEGF);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 26 条
  • [1] Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema
    Faghihi, Hooshang
    Inanloo, Bahman
    Mirzaee, Arash
    Fadakar, Kaveh
    Mirshahi, Ahmad
    Ebrahimiadib, Nazanin
    Ghassemi, Fariba
    Bazvand, Fatemeh
    Amini, Abdulrahman
    Mirghorbani, Masoud
    Faghihi, Shahin
    Pour, Elias Khalili
    Riazi-Esfahani, Hamid
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2022, 8 (01)
  • [2] The additive effect of intravitreal dexamethasone combined with bevacizumab in refractory diabetic macular edema
    Karimi, S.
    Karrabi, N.
    Hassanpour, K.
    Amirabadi, A.
    Daneshvar, K.
    Nouri, H.
    Abtahi, S. -h.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (09): : 1019 - 1029
  • [3] Intravitreal bevacizumab treatment for refractory diabetic macular edema
    Yuksel, Erdem
    Ozdek, Sengul
    Yuksel, Nilay
    Hasanreisoglu, Berati
    INTERNATIONAL OPHTHALMOLOGY, 2013, 33 (06) : 659 - 663
  • [4] Intravitreal bevacizumab treatment for refractory diabetic macular edema
    Erdem Yuksel
    Sengul Ozdek
    Nılay Yuksel
    Berati Hasanreisoglu
    International Ophthalmology, 2013, 33 : 659 - 663
  • [5] Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema
    Goel N.
    Kumar V.
    Ghosh B.
    International Ophthalmology, 2011, 31 (1) : 39 - 42
  • [6] Interferon alpha-2b addition to intravitreal bevacizumab for diabetic macular edema: a randomized controlled trial
    Karimi, Saeed
    Nouri, Mehdi
    Mansouri, Amir Reza
    Hassanzadeh, Golnar
    Nouri, Hosein
    Rikani, Saber Mohsen
    Abtahi, Seyed-Hossein
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2025, 11 (01)
  • [7] Effect of Intravitreal Triamcinolone Injection on Refractory Diabetic Macular Edema : Anatomo-Functional Correlations
    Lecleire-Collet, A.
    Pournaras, J. -A.
    Erginay, A.
    Gaudric, A.
    Massin, P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [8] Comparison Short-Term Effect of Intravitreal Triamcinolone Acetonide versus Bevacizumab Injection for Diabetic Macular Edema
    Song, J. H.
    Lee, S. J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [9] Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
    Kartasasmita, Arief
    Harley, Ohisa
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1921 - 1926
  • [10] Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema
    Jovanovic, Sandra
    Canadanovic, Vladimir
    Sabo, Ana
    Grgic, Zorka
    Mitrovic, Milena
    Rakic, Dusan
    VOJNOSANITETSKI PREGLED, 2015, 72 (10) : 876 - 882